December 14, 2017 9:53 PM ET

Biotechnology

Company Overview of TILT Biotherapeutics Ltd

Key Executives for TILT Biotherapeutics Ltd

NameBoard RelationshipsTitleAge
Akseli Hemminki M.D., Ph.D.9 RelationshipsFounder, Chairman of the Board & CEO--
Kari Hemminki No Relationships----
Elina Haavisto MScNo RelationshipsHead of Regulatory--
Aino Kalervo M.Sci, MSNo RelationshipsHead of Business Management--
Mikko Siurala Ph.D.No RelationshipsHead of Preclinical Science--
View More Key Executives

TILT Biotherapeutics Ltd Board Members*

NameBoard RelationshipsPrimary CompanyAge
Akseli Hemminki M.D., Ph.D. 9 RelationshipsTILT Biotherapeutics Ltd--
Arto Linnervuo 9 RelationshipsTILT Biotherapeutics Ltd--
Timo Ahopelto M.Sc(Tech) 25 RelationshipsLifeline Ventures Oy--
Veli-Matti Riihimäki 9 RelationshipsTILT Biotherapeutics Ltd--
Brigitte Dréno M.D., Ph.D. 27 RelationshipsOSE Immunotherapeutics SA--
View All Board Members

TILT Biotherapeutics Ltd Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
384.5K
Bonus
235.5K
Total Short Term Compensation
479.2K
Total Value of Options
18.0M
Compensation as of Fiscal Year
TILT Biotherapeutics Ltd CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Collagen Solutions plc Announces Executive Changes
December 14, 2017 7:00 AM ET
Premier Biomedical, Inc. Appoints John Pauly as Director
December 13, 2017 10:21 PM ET
ACADIA Pharmaceuticals Announces Appointment of Damien McDevitt, Ph.D., as Senior Vice President, Corporate Development
December 13, 2017 2:00 PM ET
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to Its Board of Directors
December 13, 2017 1:00 PM ET
Immunomic Therapeutics, Inc Appoints Drew Pardoll as a New Oncology Advisor to its Scientific Advisory Board
December 13, 2017 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TILT Biotherapeutics Ltd, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.